49 results on '"Abramyan, Ara M"'
Search Results
2. High-potency ligands for DREADD imaging and activation in rodents and monkeys.
3. Incorporation of Multiple β2-Hydroxy Acids into a Protein In Vivo Using an Orthogonal Aminoacyl-tRNA Synthetase
4. The Glu102 mutation disrupts higher-order oligomerization of the sigma 1 receptor
5. Incorporation of Multiple β2‑Hydroxy Acids into a Protein In Vivo Using an Orthogonal Aminoacyl-tRNA Synthetase.
6. Dynamic extracellular vestibule of human SERT: Unveiling druggable potential with high-affinity allosteric inhibitors
7. The LeuT-fold neurotransmitter : sodium symporter MhsT has two substrate sites
8. Identification of a putative binding site critical for general anesthetic activation of TRPA1
9. Incorporation of Multiple β2-Hydroxy Acids into a Protein In VivoUsing an Orthogonal Aminoacyl-tRNA Synthetase
10. Dynamic extracellular vestibule of human SERT:Unveiling druggable potential with high-affinity allosteric inhibitors
11. MetaD minima for the paper 'Atomistic simulations of the E. coli ribosome provide selection criteria for translationally active substrates'
12. Atomistic simulations of the E. coli ribosome provide selection criteria for translationally active substrates
13. An ab-initio study of pyrrole and imidazole arylamides
14. Atomistic simulations of the Escherichia coliribosome provide selection criteria for translationally active substrates
15. The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter
16. The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter
17. Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism
18. Author response: Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism
19. Computation-guided analysis of paroxetine binding to hSERT reveals functionally important structural elements and dynamics
20. A Novel Bromine-Containing Paroxetine Analogue Provides Mechanistic Clues for Binding Ambiguity at the Central Primary Binding Site of the Serotonin Transporter
21. Distinct antagonist-bound inactive states underlie the divergence in the structures of the dopamine D2 and D3 receptors
22. Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders
23. Toward Reducing HERG Affinities for Dat Inhibitors with a Combined Machine Learning and Molecular Modeling Approach
24. Mechanistic Characterization of the Allosteric Communications between the Central Binding Site and the Extracellular Vestibule of the Serotonin Transporter
25. Mechanistic Characterization of the E102Q Mutation in the Sigma 1 Receptor
26. Chemogenetic ligands for translational neurotheranostics
27. The LeuT-fold neurotransmitter:sodium symporter MhsT has two substrate sites
28. Exploring Substrate Binding in the Extracellular Vestibule of MhsT by Atomistic Simulations and Markov Models
29. Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays
30. The action of a negative allosteric modulator at the dopamine D2 receptor is dependent upon sodium ions
31. The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors
32. Structure–Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders
33. The Isomeric Preference of an Atypical Dopamine Transporter Inhibitor Contributes to Its Selection of the Transporter Conformation
34. The Isomeric Preference of an Atypical Dopamine Transporter Inhibitor Contributes to Its Selection of the Transporter Conformation
35. Exploring Ligand-Binding Kinetics in the S2 Site of MhsT by Atomistic Simulations and Markov Models
36. Inside Cover: Computational Prediction and Rationalization, and Experimental Validation of Handedness Induction in Helical Aromatic Oligoamide Foldamers (Chem. Eur. J. 15/2017)
37. Computational Prediction and Rationalization, and Experimental Validation of Handedness Induction in Helical Aromatic Oligoamide Foldamers
38. Structure–Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders
39. Towards Identifying Biologically Relevant Intermediate Conformational States in Dopamine Transporter
40. Helix handedness inversion in arylamide foldamers: elucidation and free energy profile of a hopping mechanism
41. The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors.
42. Structure-Activity Relationship Studies on a Series of 3a-[Bis(4-fluorophenyl)methoxy]tropanes and 3a-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders.
43. Helical arylamide foldamers: structure prediction by molecular dynamics simulations
44. Identification of a putative binding site critical for general anesthetic activation of TRPA1.
45. Mechanistic and dynamic insights into ligand encapsulation by helical arylamide foldamers
46. The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors
47. Incorporation of Multiple β 2 -Hydroxy Acids into a Protein In Vivo Using an Orthogonal Aminoacyl-tRNA Synthetase.
48. The action of a negative allosteric modulator at the dopamine D 2 receptor is dependent upon sodium ions.
49. Computational Prediction and Rationalization, and Experimental Validation of Handedness Induction in Helical Aromatic Oligoamide Foldamers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.